SCHEMBL6087232

SCHEMBL6087232

CCOC(=O)C(CCCOc1ccc2ccccc2c1)Nc1ccc(OC)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 5/20 0.54
TDP1 Q9NUW8 2/20 0.52
ALDH1A1 P00352 2/20 0.52
TSHR P16473 1/20 0.52
MAPK1 P28482 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
PPARD Q03181 2/20 0.47
PPARA Q07869 2/20 0.47
POLB P06746 2/20 0.45
NCOA2 Q15596 1/20 0.45
NCOA1 Q15788 1/20 0.45
CTDSP1 Q9GZU7 1/20 0.45
NCOA3 Q9Y6Q9 1/20 0.45
RAB9A P51151 4/20 0.44
NPC1 O15118 3/20 0.44
CASP3 P42574 1/20 0.44
SENP7 Q9BQF6 1/20 0.44
RECQL P46063 1/20 0.43
HDAC1 Q13547 1/20 0.43
MEN1 O00255 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28774738 0.81 TAS1R3 (0.51) TDP1ALDH1A1MAPK1L3MBTL1POLB
SCHEMBL28416132 0.79 MMP9 (0.47) L3MBTL1POLBKMT2A
SCHEMBL29237378 0.78 ALDH1A1 (0.52) ALDH1A1MAPK1L3MBTL1POLBRAB9A
SCHEMBL5339626 0.76 CA12 (0.52) ALDH1A1MAPK1L3MBTL1RAB9ANPC1
SCHEMBL24103891 0.75 L3MBTL1 (0.44) ALDH1A1L3MBTL1HDAC1KMT2A
SCHEMBL5701779 0.75 PPARG (0.58) PPARGTDP1MAPK1PPARDPPARA
SCHEMBL4424175 0.75 DHODH (0.48) ALDH1A1L3MBTL1POLBRAB9ANPC1
SCHEMBL813251 0.73 CA12 (0.50) ALDH1A1MAPK1L3MBTL1RAB9ANPC1
SCHEMBL29283528 0.73 KMT2A (0.51) ALDH1A1MAPK1L3MBTL1POLBMEN1
SCHEMBL13395861 0.72 CA12 (0.49) ALDH1A1MAPK1L3MBTL1RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7081465-B2 Alpha-substituted naphthyloxy omega-substituted alky/aryl amino-substituted alkane derivatives as agent for treatment or prophylaxis of diabetes and related metabolic disorders COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2006-07-25 US claimed